HOME: Home Monitoring of High-risk Pregnancies
Launched by OSLO UNIVERSITY HOSPITAL · Mar 9, 2023
Trial Information
Current as of June 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Preeclampsia
- • Gestational Hypertension
- • Premature Preterm Rupture of Membranes
- • High Risk Pregnancy
- • Previous adverse obstetric outcomes
- Exclusion Criteria:
- • Multiples (twins, triplets etc)
- • Patient or fetus in immediate need for delivery
- • Not understanding Norwegian
- • Not mastering the technological aspects of home monitoring
- • Long travel distance to Obstetric Department
About Oslo University Hospital
Oslo University Hospital is a leading academic medical center in Norway, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes the development of new therapies and treatment strategies. With a multidisciplinary approach, Oslo University Hospital collaborates with various stakeholders, including researchers, healthcare professionals, and industry partners, to enhance clinical outcomes and contribute to the global medical community. Its dedication to ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and respect for participant welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Patients applied
Trial Officials
Anne Cathrine Staff, MD, PhD
Principal Investigator
Oslo University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials